Researchers discover potential treatment for sepsis and other responses to infection

Researchers at the Icahn School of Medicine at Mount Sinai say that tiny doses of a cancer drug may stop the raging, uncontrollable immune response to infection that leads to sepsis and kills up to 500,000 people a year in the U.S. The new drug treatment may also benefit millions of people worldwide who are affected by infections and pandemics.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news